Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Insights Into Imaging|August 1, 2024
The policies on the use of large language models in radiological journals are lacking: a meta-research studyJingyu Zhong, Yue Xing, Yangfan Hu, et al.
International Journal of Cancer|September 5, 2022
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancerGuanghui Gao, Longgang Cui, Fei Zhou, et al.
European Radiology|January 9, 2025
Overlooked and underpowered: a meta-research addressing sample size in radiomics prediction models for binary outcomesJingyu Zhong, Xianwei Liu, Junjie Lu, et al.
Thoracic Cancer|February 24, 2024
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung diseaseChuchu Shao, Xinxin Zhi, Shiqi Mao, et al.
Journal of Cancer|January 17, 2020
Cell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung CancerZhengwei Dong, Yiwei Liu, Tao Jiang, et al.
European Radiology|November 6, 2024
Node-RADS: a systematic review and meta-analysis of diagnostic performance, category-wise malignancy rates, and inter-observer reliabilityJingyu Zhong, Shiqi Mao, Haoda Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2019
Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLCShuo Yang, Shiqi Mao, Xuefei Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2023
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusionYingying Pan, Xinyu Liu, Wei Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase Inhibitor Resistance in NSCLCShiqi Mao, Xinyu Liu, Lin Wang, et al.
Translational Lung Cancer Research|March 15, 2021
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutationsShuo Yang, Yan Wang, Chao Zhao, et al.
Pageof 5